Apr 21, 2025, 18:07

The NCI Predoctoral to Postdoctoral Fellow Transition Award

The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) Award supports outstanding PhD or research doctoral candidates in completing their dissertation (F99 phase) and transitioning into a cancer-focused postdoctoral research position (K00 phase). The award offers up to 6 years of support to facilitate this transition and promote a successful independent research career.

Eligibility

Predoctoral students in their 3rd or 4th year of a health-related PhD program
Must be nominated by their institution
Must not have accepted a postdoctoral position or completed PhD requirements at the time of award
No citizenship restrictions; applicants must have a valid U.S. visa that permits research activity throughout the award
F99 phase: Full-time effort (40 hrs/week)
K00 phase: Minimum 75% professional effort

Grant Term and Budget

F99 Phase (up to 2 years):
- Stipend: Same as F31 NRSA (currently 28,224 USD)
- Tuition/Fees: 60% of combined cost, up to 16,000 USD/year
- Institutional Allowance: Includes 1,500 USD for travel to NCI conference
K00 Phase (up to 4 years):
- Salary: 65,000 USD (Year 1), 69,000 USD (Year 2), 72,000 USD (Year 3), 76,000 USD (Year 4)
- Tuition/Fees: Up to 4,500 USD/year
- Research Support: Up to 3,000 USD/year, plus 1,500 USD travel to NCI conference
Indirect Costs: 8% of modified total direct costs

Application Deadline

Next Deadline: November 19, 5:00 p.m. local time
One submission date per fiscal year
If due date falls on weekend/holiday, deadline extends to next business day

How to Apply

Applications must be submitted electronically via SF424 (R&R)
Must follow specific instructions outlined in the F99/K00 Funding Opportunity Announcement (RFA-CA-23-042)
Must include institutional nomination letter
Applications must have two Specific Aims:
- Aim 1: Dissertation Research
- Aim 2: Postdoctoral Research Direction

K00 Transition

Requires a secured postdoctoral position
Transition application includes updated aims, mentor statements, budget, environment, visa info (if applicable), and research plan updates

biomedical research support cancer Cancer Education cancer research career development cancer research fellowships doctoral training in oncology F99 K00 fellowship NCI F99 K00 NCI training grant NIH fellowships OncoDaily Oncology PhD to postdoc transition postdoctoral transition

Oliver Bogler Announced the Launch of the NanCI AI Webapp for Scientific Literature and Networking

Joe Biden Diagnosed with Aggressive Metastatic Prostate Cancer at Age 82

DESTINY-Breast06 Trial Updates at ESMO Breast 2025 Confirms T-DXd Efficacy in HER2-Low and Ultralow Metastatic Breast Cancer

FDA Approves Belzutifan (Welireg) for Advanced Pheochromocytoma and Paraganglioma: Results of LITESPARK-015 Trial

New World Cancer Declaration 2025–2035 by UICC